Jagsonpal Pharmaceuticals Ltd Announces Q2 and H1 Results for FY2025-26, Net Profit at INR 167.88 Million

Jagsonpal Pharmaceuticals Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported a net profit of INR 167.88 million for the quarter and INR 698.59 million for the half year. The revenue from operations stood at INR 2,769.06 million for the quarter. The total income for the quarter was INR 2,769.06 million and for the half year was INR 5,017.22 million. The total expenses for the quarter were INR 2,267.34 million and for the half year were INR 4,572.58 million. The company's earnings per share (basic and diluted) for the quarter were INR 1.26 and INR 1.26 respectively.